|
COPD
|
Control subjects
| |
---|
Type of infection | N | Incidence1
| N | Incidence1
| HR2
|
---|
Pnemonia | 8,581 | 983 (963–1,004) | 2,638 | 188 (181–195) | 4.7 (4.4-4.9) |
Skin infection | 698 | 80 (74–86) | 331 | 24 (21–26) | 3.3 (2.8-3.8) |
CNS infection | 18 | 2.0 (1.3-3.2) | 23 | 1.6 (1.1-2.4) | 1.1 (0.6-2.3)3
|
Endocarditis | 60 | 6.9 (5.3-8.9) | 34 | 2.4 (1.7-3.4) | 2.8 (1.7-4.7) |
Pyelonephritis | 500 | 57 (52–62) | 300 | 22 (20–24) | 2.4 (2.0-2.9) |
Septic arthritis | 93 | 10.7 (9.7-13.1) | 80 | 5.7 (4.6-7.1) | 1.9 (1.3-2.6) |
-
1- Crude incidence of hospitalizations for infectious diseases per 10,000 person-years of follow-up. Infectious episodes were separated by >30 days for pneumonia, skin infection, CNS infection and pyelonephritis and >60 days for endocarditis and septic arthritis. 2-Hazard ratio of time to first hospitalization for infection estimated by Cox regression using time since inclusion as the time scale and stratified for age, year of birth and gender and adjusted for socio-economic status and co-morbidity. 3-Due to the limited number of outcomes, this Cox model was only adjusted for any co-morbidity (yes/no) prior to inclusion.